Black Diamond Therapeutics, Inc.
BDTX
$3.05
$0.113.74%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 14.44M | 5.09M | -69.68M | -73.10M | -80.55M |
| Total Depreciation and Amortization | 344.00K | 344.00K | 343.00K | 344.00K | 373.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.50M | 10.25M | 9.72M | 9.50M | 11.12M |
| Change in Net Operating Assets | -4.41M | -3.38M | -2.69M | 2.05M | 814.00K |
| Cash from Operations | 17.87M | 12.31M | -62.30M | -61.20M | -68.24M |
| Capital Expenditure | -- | -- | -- | 0.00 | -33.00K |
| Sale of Property, Plant, and Equipment | 79.00K | 107.00K | 94.00K | 86.00K | 38.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -20.72M | 39.14M | 16.87M | 1.36M | -38.63M |
| Cash from Investing | -20.64M | 39.25M | 16.97M | 1.45M | -38.63M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 323.00K | 21.70M | 25.80M | 25.51M | 97.44M |
| Repurchase of Common Stock | -368.00K | -252.00K | -252.00K | -298.00K | -46.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -45.00K | 21.45M | 25.55M | 25.21M | 97.39M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.82M | 73.00M | -19.79M | -34.55M | -9.48M |